Predict your next investment

HEALTHCARE | Drug Development
therabron.com

See what CB Insights has to offer

Total Raised

$21.62M

Investors Count

4

Deal Terms

2

Therabron Therapeutics Funding, Therabron Therapeutics Valuation & Therabron Therapeutics Revenue

6 Fundings

Therabron Therapeutics's latest funding round was a Debt for $2.33M on December 27, 2016.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/27/2016

Debt

$2.33M

Undisclosed Investors

$0.00B

((9.99x))

FY 1234

1

11/9/2015

Series B - II

$99M

$0.00B

((9.99x))

FY 1234

10

12/18/2014

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

9/24/2012

Grant

$99M

$0.00B

((9.99x))

FY 1234

10

9/18/2012

Series A - II

$99M

$0.00B

((9.99x))

FY 1234

10

Date

12/27/2016

11/9/2015

12/18/2014

9/24/2012

9/18/2012

Round

Debt

Series B - II

Series B

Grant

Series A - II

Amount

$2.33M

$99M

$99M

$99M

$99M

Investors

Undisclosed Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

10

10

10

Therabron Therapeutics Deal Terms

2 Deal Terms

Therabron Therapeutics's deal structure is available for 2 funding rounds, including their Series B from December 18, 2014.

Round

Series B

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

Therabron Therapeutics Investors

4 Investors

Therabron Therapeutics has 4 investors. New Markets Venture Partners invested in Therabron Therapeutics's Series B - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/18/2014

11/9/2015

2
Series B, Series B - II (2015)

Venture Capital

Maryland

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Corporate Venture

Maryland

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

DC

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Government

DC

First funding

12/18/2014

00/00/0000

00/00/0000

00/00/0000

Last Funding

11/9/2015

00/00/0000

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Rounds

2
Series B, Series B - II (2015)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Subscribe to see more

Type

Venture Capital

Corporate Venture

Venture Capital

Government

Location

Maryland

Maryland

DC

DC

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.